CERo Therapeutics Holdings, Inc. (CERO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CERO
- Company CERo Therapeutics Holdings, Inc.
- Price $0.96
- Changes Percentage -29.4
- Change -0.3998
- Day Low $0.93
- Day High $1.28
- Year High $376
- Year Low $0.93
- Market Cap $2,909,342
- Price Avg 50 EMA (D) $2.41
- Price Avg 200 EMA (D) $16.54
- Exchange NASDAQ
- Volume 5,936,452
- Average Volume 762,653
- Open $1.25
- Previous Close $1.36
- EPS -118.56
- PE -0.01
- Earnings Announcement 2025-03-11 04:00:00
- Shares Outstanding $3,029,933
Company brief: CERO THERAPEUTICS HOLDINGS, INC. (CERO )
- Healthcare
- Biotechnology
- Mr. Brian G. Atwood
- https://www.cero.bio
- US
- N/A
- 11-30-2021
- US71902K1051
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.